Download PDF
Am J Perinatol 2002; 19(3): 155-162
DOI: 10.1055/s-2002-25314
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Functional Residual Capacity (FRC) Does Not Predict Response to Surfactant in Preterm Infants

Mariette Dermendjian, Swati Varma, Alfred N. Krauss, Peter A.M. Auld
  • Perinatology Center, Department of Pediatrics, New York Hospital-Cornell Medical Center, New York, New York
Further Information

Publication History

Publication Date:
25 April 2002 (online)

    Permissions and Reprints

ABSTRACT

We tested the hypothesis that the initial functional residual capacity (FRC) of preterm infants with hyaline membrane disease (HMD) could predict the response to surfactant replacement (Survanta, 4 mL/kg/dose), with a better initial FRC being correlated with a greater improvement in PaO2, a/A PO2 ratio, and FRC. Thirty-four preterm infants were studied on 41 occasions. FRC and arterial blood gases were measured immediately prior to treatment. FRC was measured by the helium dilution method. Arterial blood gases were measured again after 30, 60, and 120 minutes. FRC was measured after 120 minutes. Twenty-seven treatments resulted in an increase in PaO2 >10 mmHg (responders); 14 did not (nonresponders). There was no correlation between initial FRC, change in FRC, and change in PaO2 (r 2 = 0.07). These results suggest that there is no relationship between initial FRC and response to surfactant treatment.

KEYWORD

FRC - arterial/alveolar PO2 ratio - surfactant replacement - hyaline membrane disease - preterm infants

REFERENCES

  • 1 Avery M E, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease.  Am J Dis Child . 1959;  97 517-523
    PubMedGoogle Scholar
  • 2 Auld P AM, Nelson N M, Cherry R B, Rudolph A J, Smith C A. Measurement of thoracic gas volume in the newborn infant.  J Clin Invest . 1963;  42 476-483
    PubMedGoogle Scholar
  • 3 Gribetz I, Frank N R, Avery M E. Static volume-pressure relations of excised lungs of infants with hyaline membrane disease of the newborn infant.  J Clin Invest . 1959;  38 2168-2175
    PubMedGoogle Scholar
  • 4 Gruenwald P. Normal and abnormal expansion of the lungs of newborn infants obtained at autopsy: II. Opening pressure, maximal volume, and stability of expansion.  Lab Invest . 1963;  12 563-576
    PubMedGoogle Scholar
  • 5 Karlberg P, Cook C D, O'Brien D, Cherry R B, Smith C A. Studies of respiratory physiology in the newborn infant: observations during and after respiratory distress.  Acta Paediatr . 1954;  43(Suppl 100) 397-411
    PubMedGoogle Scholar
  • 6 Tori C A, Krauss A N, Auld P AM. Serial studies of lung volume and VA/Q in hyaline membrane disease.  Pediatr Res . 1973;  7 82-88
    PubMedGoogle Scholar
  • 7 Krauss A N, Auld P AM. Measurement of functional residual capacity in distressed neonates by helium rebreathing.  J Pediatrics . 1970;  77 228-232
    PubMedGoogle Scholar
  • 8 Kwong M S, Egan E A, Notter R H, Shapiro D L. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants.  Pediatrics . 1985;  76 585-592
    PubMedGoogle Scholar
  • 9 Kendig J W, Notter R H, Cox C. Surfactant replacement therapy at birth: final analysis of a clinical trial and comparison with similar trials.  Pediatrics . 1988;  82 756-762
    PubMedGoogle Scholar
  • 10 Bose C, Corbet A, Bose G. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.  J Pediatr . 1990;  117 947-953
    PubMedGoogle Scholar
  • 11 Merritt T A, Hallman M, Berry C. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants.  J Pediatr . 1991;  118 581-594
    PubMedGoogle Scholar
  • 12 Long W, Thompson T, Sundell H, Schumacher R, Volberg F, Guthrie R. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome.  J Pediatr . 1991;  118 595-605
    PubMedGoogle Scholar
  • 13 Charon A, Taeusch H W, Fitzgibbon C, Smith G B, Treves S T, Phelps D S. Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome.  Pediatrics . 1989;  83 348-354
    PubMedGoogle Scholar
  • 14 Wallenbrock M A, Sekar K C, Toubas P L. Prediction of the acute response to surfactant by pulmonary function testing.  Pediatr Pulmonol . 1992;  13 11-15
    PubMedGoogle Scholar
  • 15 Krauss A N, Auld P AM. Pulmonary gas trapping in premature infants.  Pediatr Res . 1971;  5 10-16
    PubMedGoogle Scholar
  • 16 Gilbert R, Keighley J F. The arterial/alveolar oxygen tension ratio: an index of gas exchange applicable to varying inspired oxygen concentrations.  Am Rev Resp Dis . 1974;  109 142-145
    PubMedGoogle Scholar
  • 17 Bowen W, Martin C R, Krauss A N, Auld P AM. Ventilation-perfusion relationships in preterm infants after surfactant treatment.  Pediatr Pulmonol . 1994;  18 155-162
    CrossrefPubMedGoogle Scholar
  • 18 Croxton F E. Elementary Statistics with Applications in Medicine and the Biological Science.  New York: Dover Publications 1959
    Google Scholar
  • 19 Sandberg K, Edberg K E, Benton W W, Silberberg A, Sladek M, Sundell H W. Surfactant improves gas mixing and alveolar ventilation in preterm lambs.  Pediatr Res . 1991;  30 181-189
    PubMedGoogle Scholar
  • 20 Vilstrup C, Gommers D, Bos J AH, Lachmann B, Werner O, Larsson A. Natural surfactant instilled in premature lambs increases lung volume and improves ventilation homogeneity within five minutes.  Pediatr Res . 1992;  32 595-599
    PubMedGoogle Scholar
  • 21 Bambang Oetomo S, Reijngoud D-J, Ennemb J J, Okken A, Wildebur C RH. Surfactant replacement therapy in surfactant deficient rabbits: early effects on lung function and biochemical aspects.  Lung . 1988;  166 65-73
    PubMedGoogle Scholar
  • 22 Cotton R B, Olsson T, Law A B. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.  Pediatr Res . 1993;  34 495-501
    PubMedGoogle Scholar
  • 23 Edberg K E, Ekstrom-Jodal B, Hallman M, Hjalmarson O, Sandberg K, Silberberg A. Immediate effects on lung function of instilled human surfactant in mechanically ventilated newborn infants with IRDS.  Acta Paediatr Scand . 1990;  79 750-755
    PubMedGoogle Scholar
  • 24 Farhi L E. Ventilation-perfusion relationship and its role in alveolar gas exchange. In: Caro CG, ed. Advances in Respiratory Physiology Baltimore: Williams and Wilkins 1966: 148-197
    Google Scholar
  • 25 West J B. Ventilation/Blood Flow and Gas Exchange.  5th ed. Oxford, England: Blackwell Scientific Publications 1990: 80-94
    Google Scholar
  • 26 Krauss A N, Auld P AM. Ventilation-perfusion abnormalities in the premature infant: triple gradient.  Pediatr Res . 1969;  3 255-264
    PubMedGoogle Scholar
  • 27 Hand I L, Shepard E K, Krauss A N, Auld P AM. Ventilation-perfusion abnormalities in the preterm infant with hyaline membrane disease: a two-compartment model of the neonatal lung.  Pediatr Pulmonol . 1990;  9 206-213
    PubMedGoogle Scholar
      >